Eli Lilly launches Alzheimer’s drug Donanemab in India
By Rishika Sadam May 13 (Reuters) – U.S.-based drugmaker Eli Lilly on Wednesday launched its Alzheimer’s ‌drug Lormalzi, also known as Donanemab, ‌in India. Here are the details: • The drugmaker has priced ​the 350 mg vial of Lormalzi at 91,688 rupees ($957), the company told Reuters • The drug is expected to become commercially…
